John Wiley and Sons Inc., (NYSE:JWA) (NYSE:JWB) today announced its
partnership with The Australasian Medical Publishing Company Pty Ltd
(AMPCo) to publish the Medical Journal of Australia (MJA).
The MJA is produced by AMPCo, a wholly owned subsidiary of the
Australian Medical Association (AMA) — the most influential membership
organisation representing registered medical practitioners and medical
students of Australia.
In the top 20 general medical journals globally, the MJA is the leading
general medical journal in the Asia–Pacific region. The MJA covers
issues surrounding Australian health care, clinical research and
practices and developments within medicine. Wiley will assume online
publishing and distribution responsibilities in January 2019. The
partnership will provide institutional customers with access to the MJA
via the Wiley
Online Library platform.
Laureate Professor Nicholas Talley, AC, the Editor-in-Chief of the MJA
said, “Australia deserves a great journal that represents and promotes
the world-class medical research coming out of Australia. The goal of
the MJA is editorial excellence, growing our impact and global presence
while maintaining the relevance of the MJA to Australian medical and
allied health researchers and clinicians. The MJA will maintain the
editorial independence it has enjoyed since its foundation in 1914.
Content selection, review and development, and scientific and copy
editing will continue to be performed in-house by our dedicated team of
medical, structural and scientific editors.”
MJA research articles and content related to Aboriginal and Torres
Strait Islander health will continue to be freely available to all
readers. An MJA app will also be launched, and back issues will be
digitized and available on Wiley
Online Library from 2019.
“Wiley is the leading publishing partner for academic society and
association journals,” said Delores D’Costa, Executive General Manager
of AMPCo. “Wiley has the technology, global reach and customer
relationships and infrastructure to support our strategic goals of
growth in our subscriber base, readership and discoverability beyond the
Australian market. The MJA team looks forward to this exciting new
chapter in the history of Australia’s premier medical journal,
sustaining its commitment to improving Australia’s health by delivering
evidence needed for effective and efficient health research, practice
and policy.”
“As the leading publisher of medical journals from Australia, Wiley is
delighted to be partnering with AMPCo to publish the MJA,” said Deborah
Wyatt, Vice President of Society Services, Asia–Pacific, Wiley. “We look
forward to engaging with the MJA’s editorial team to help amplify the
real-world impact of their published research in important areas such as
public and Indigenous health.”
“We at Wiley are thrilled to be working with AMPCo,” said Brian Napack,
President and Chief Executive Officer, Wiley. “The MJA, under the
leadership of Professor Nicholas Talley, is a very prestigious addition
to our health science publishing family. We are looking forward to
working together to further develop the journal’s global impact.”
AMA members can continue to access the Journal electronically via the MJA.com.au
website. The print format of the MJA will continue to be published and
distributed as a benefit to AMA members and paid subscribers by AMPCo.
About the Medical Journal of Australia:
The Medical Journal of Australia (MJA) is Australia’s most
influential peer reviewed journal, consistently cited and referenced in
the media. MJA is a general medical journal publishing 22 issues
per year. The MJA is published by the Australasian Medical
Publishing Company (AMPCo) LTD, a wholly owned subsidiary of the
Australian Medical Association. AMPCo has been serving Australian
doctors and enabling better health care outcomes through trusted content
and services since 1903. www.ampco.com.au.
About Wiley:
Wiley, a global research and learning company, helps people and
organizations develop the skills and knowledge they need to succeed. Our
online scientific, technical, medical, and scholarly journals, combined
with our digital learning, assessment and certification solutions help
universities, learned societies, businesses, governments and individuals
increase the academic and professional impact of their work. For more
than 210 years, we have delivered consistent performance to our
stakeholders. The company's website can be accessed at www.wiley.com.
Wiley Media:
Tom Griffin (UK), +44 (0) 1865 476213
Canon Carson, +1-201-748-5838
sciencenewsroom@wiley.com
Follow us on Twitter @WileyNews
or
MJA Media:
Cate Swannell (Aus), +61 418 188806
cswannell@mja.com.au
Follow us on Twitter @theMJA